• Medicină
  • 22 iulie
  • FDA to approve Sanofi's Subcutaneous Sarclisa
    2
  • FDA to approves Elevar Therapeutics' Rivoceranib + camrelizumab
    2
  • 28 iulie
  • FDA approves Outlook Therapeutics' ONS-5010
    2
  • 30 iulie
  • FDA to approves Viatris' low-dose estrogen weekly patch
    2
  • 31 iulie
  • Measles cases in U.S. by July 31
    6
  • 30 decembrie
  • FDA approves Retatrutide this year
    2
  • FDA to approve Daraxonrasib this year
    2